Marijuana Medical Program (MMP)

The New Jersey Medical Marijuana Program allows the use of medically recommended marijuana for the following conditions:

• Amyotrophic lateral sclerosis (ALS)
• Multiple sclerosis (MS)
• Chronic pain or weight loss from cancer
• Muscular dystrophy
• Inflammatory bowel disease, including Crohn’s disease or ulcerative colitis
• Terminal illness, if the physician has determined a prognosis of less than 12 months of life.
• Seizure disorder
• Intractable skeletal muscular spasticity
• Glaucoma
• Positive status for human immunodeficiency virus (HIV)
• Acquired immune deficiency syndrome (AIDS)
• Post-Traumatic Stress Disorder (PTSD)
• Anxiety
• Chronic Migraines
• Chronic pain of visceral origin
• Chronic pain related to musculoskeletal disorders
• Tourette’s Syndrome

The following conditions apply, if resistant to, or if the patient is intolerant to, conventional therapy:

• Seizure disorder, including epilepsy
• Intractable skeletal muscular spasticity
• Glaucoma

The following conditions apply, if severe or chronic pain, severe nausea or vomiting, cachexia or wasting syndrome results from the condition or treatment thereof:

• Positive status for human immunodeficiency virus
• Acquired immune deficiency syndrome
• Cancer

Other Conditions not Recognized by the NJ MMP. The NJMMP is relatively restrictive and other states with legal medical marijuana have noted its efficacy in other conditions including;

• Chronic neuropathic pain, including nerve damage, phantom limb pain, facial neuralgia, and post herpetic neuralgia
• Nausea and vomiting from medication for the treatment of hepatitis C
• Neuropsychiatric disorders, including tics associated with Tourette syndrome, neuropathy, Parkinson’s disease, and Post Traumatic Stress Disorder(PTSD)
• Autoimmune conditions, including arthritis and lupus
• A debilitating symptom associated with a medical condition or the medical treatment of that condition